David Siwicki

Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic.

Kenneth Blum, William Jacobs, Edward J. Modestino et al. · PubMed · 2018 · 56 citations · Full text

Opioid Epidemic, Pain Therapy, Pain Disorders +30

Hypodopaminergia and “Precision Behavioral Management” (PBM): It is a Generational Family Affair

Lyle Fried, Edward J. Modestino, David Siwicki et al. · Current Pharmaceutical Biotechnology · 2019 · 53 citations

Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD)

Kenneth Blum, Abdalla Bowirrat, Baron D et al. · Journal of Systems and Integrative Neuroscience · 2020 · 40 citations · Full text

In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing

Kenneth Blum, David Baron, Lisa Lott et al. · Current Psychopharmacologye · 2019 · 33 citations · Full text

The Benefits of Genetic Addiction Risk Score (GARS^™) Testing in Substance Use Disorder (SUD).

Kenneth Blum, Edward J. Modestino, Marjorie C. Gondré‐Lewis et al. · PubMed · 2018 · 28 citations